Pharma & Biotech
Accelerating Drug Development, Empowering Innovation
Empiric partners with pharma and biotech companies to streamline the clinical trial process, enabling smarter and faster drug development through adaptive trial designs and automation technology.
Smarter Designs, Faster Breakthroughs
Our adaptive trial designs significantly reduce the time needed to bring new drugs to market by up to 50%. By incorporating interim analyses and real-time data, we allow for smarter go/no-go decisions, helping you reach critical milestones faster and with greater confidence.
Maximising Efficiency, Minimising Waste
Empiric’s trial designs are tailored to optimise your resource allocation, reducing unnecessary costs and focusing on what truly matters—delivering effective treatments. This approach not only saves time but also ensures that every dollar spent contributes to a higher probability of success.
.png)
.png)
Smarter Trials, Higher Success
By leveraging real-world data and sophisticated automation technology, our trials are designed to adapt to emerging data, improving your trial’s likelihood of success. This results in better outcomes and stronger confidence from investors and regulatory bodies alike.
.png)
.png)
